Human natural killer cell receptors and co-receptors

Immunological Reviews

Volumn 181, Issue , 2001, Pages 203-214

  Biassoni, Roberto ^a,e   Cantoni, Claudia ^b,c   Pende, Daniela ^a   Sivori, Simona ^b,c   Parolini, Silvia ^d   Vitale, Massimo ^a   Bottino, Cristina ^a   Moretta, Alessandro ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2B4 RECEPTOR; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; NKP80 RECEPTOR; UNCLASSIFIED DRUG;

CELL ACTIVATION; CYTOLYSIS; CYTOTOXICITY; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; X CHROMOSOME LINKAGE;

CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

EID: 0034895083     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1810117.x     Document Type: Review

References (155)

1. Biology of natural killer cells
2. Activation and function of natural killer cell responses during viral infections
3. Implications for immunosurveillance of altered HLA-class I penotypes in human tumours
4. MHC molecules in normal and neoplastic cells
5. Viral strategies of immune evasion
6. In search of the "missing self". MHC molecules and NK cell recognition
7. Allorecognition by NK cells: Nonself or no self?
8. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6
9. Receptors for HLA-class I molecules in human natural killer cells
10. NK cell receptors
11. Regulation of immune responses through inhibitory receptors
12. Major histocompability complex class I-specific receptors on human natural killer and T lymphocytes
13. Arousal and inhibition of human NK cells
14. Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules
15. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
16. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis
17. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
18. p46, a novel natural killer cell-specific surface molecule which mediates cell activation
19. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
20. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
21. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis
22. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
23. Family of disulphide-linked dimers containing the ζ and η chains of the T-cell receptor and the γ chain of Fc receptors
24. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
25. Immunoreceptor DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells
26. Association of DAP12 with activating CD94/NKG2C NK cell receptors
27. An activating immunoreceptor complex formed by NKG2D and DAP10
28. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
29. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
30. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
31. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in NK cells
32. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains
33. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
34. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
35. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
36. Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones
37. The natural killer receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptor that is characterized by three immunoglobulin-like domain and is expressed as a 140 kDa disulphide-linked dimer
38. A human killer inhibitory receptor specific for HLA-A
39. p49, a putative HLA class I-specific receptor belonging to the immunoglobulin superfamily
40. NK cell receptor gene of the KIR family with two Ig domains but highest homology to KIR receptors with three Ig domains
41. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
42. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
43. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
44. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
45. + NK cell clones
46. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors
47. The CD94 and NKG2-A C-type lectins covalently assamble to form a a NK cell inhibitory receptor for HLA class I molecules
48. Human natural killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits
49. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
50. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
51. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
52. NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor
53. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
54. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
55. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
56. Inhibitory pathways triggered by ITIM-containing receptors
57. Of ITAMs and ITIMs: Turning on and off the B cell antigen receptor
58. Human and mouse killer-cell inhibitory receptor recruit PTP1C and PTP1D protein tyrosine phosphatases
59. Recruitment of tyrosine phosphatase HCP by the killer inhibitory receptor
60. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein phosphatase 1C
61. lck kinase
62. Transduction of cytotoxic signals in natural killer cells: A general model of fine tuning between activatory and inhibitory pathways in lymphocytes
63. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
64. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA.C molecules in human natural killer cells
65. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
66. The activating form of CD94 receptor complex. CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
67. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for Cw4 molecules
68. Amino acid substitution can influence the NK- mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones
69. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
70. Structure of the inhibitory receptor for human natural killer cells resembles haemopoietic receptors
71. The HLA.C specific "activatory" and "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
72. Identification of natural p50.2/KIR2DS mutants unable to transduce activating signals
73. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
74. Peptide specificity in the recognition of MHC class I by natural killer cell clones
75. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
76. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor
77. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex
78. Organization of the leukocyte cluster (LRC) on human chromosome 19q13.4
79. Divergent and convergent evolution of NK-cell receptors
80. A multigene family on human chromosome 12 encodes natural killer-cell lectins
81. The human natural killer gene complex is located on chromosome 12p12-p13
82. The Ly-49 family: Genes, proteins, and recognition of class I MHC
83. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
84. Killer cell receptors: Keeping pace with MHC class I evolution
85. Plasticity in the organization and sequences of human KIR/ILT gene families
86. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
87. Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes
88. p40, a novel surface molecule involved in the regulation of the non-MHC restricted cytolytic activity in humans
89. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes
90. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells
91. Arrangement of the ILT gene cluster: A common null allele of the ILT6 gene results from a 6.7-kbp deletion
92. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells
93. Identification and molecular cloning of p75/AIRM1 a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells
94. The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor
95. Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor
96. The human transmembrane secretory component (poly-Ig receptor): Molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization
97. The CMRF-35 H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17
98. Identification and characterization of a novel Siglec, Siglec-7, expressed by human natural killer cells and monocytes
99. Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells
100. Molecular cloning of a novel gene similar to myeloid antigen CD33 and its specific expression in placenta
101. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells
102. A novel inhibitory receptor (ILT-3) expressed on monocytes, macrophages and dendritic cells involved in antigen processing
103. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor
104. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity
105. Identification of the rat homologue of the human NKp46 triggering receptor
106. Expression and cellular localization of the protein encoded by the 1C7 gene: A recently described component of the MHC
107. Phenotypic and functional characterization of recombinant interleukin-2 (rIL-2)-induced killer cells: Analysis at the population and the clonal level
108. Cancer immunotherapy-2 and interleukin-2-activated lymphocytes
109. Genes in a 220-kb region spanning the TNF duster in human MHC
110. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC
111. Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
112. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
113. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
114. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
115. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2
116. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
117. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
118. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
119. The molecular and functional characterization of a dominant minor H antigen, H60
120. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain
121. 2B4 functions as a coreceptor in human natural killer cell activation
122. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery
123. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
124. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
125. Activation of murine epidermal γδ T cells through surface 2B4
126. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
127. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
128. Activating interactions in human NK cell recognition: The role of 2B4-CD48
129. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
130. Identification of the 2B4 molecule as a counter-receptor for CD48
131. The structure and ligand interactions of CD2: Implications for T-cell function
132. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells
133. A novel receptor involved in T-cell activation
134. CD84 leukocyte antigen is a new member of the Ig superfamily
135. Isolation and characterization of cDNA clones for moose Ly-9
136. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4
137. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of NK cells to kill EBV-infected cells
138. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
139. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: Evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells
140. LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation
141. A role for the adaptor protein LAT in human NK cell-mediated cytotoxicity
142. Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction
143. CD4, CD8 and the TCR-CD3 complex: A novel class of protein-tyrosine kinase receptor
144. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)
145. Fatal infections mononucleosis in familial lymphohistiocytosis
146. X-linked lymphoproliferative disease: Twenty-five years after the discovery
147. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
148. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
149. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM
150. Defective NK cell activation in X-linked lymphoproliferative disease
151. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
152. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression
153. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
154. Identification of NKp80 a novel triggering molecule expressed by human natural killer cells
155. Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: Molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis